{
  "id": "d21c64ebfa264f06",
  "title": "Aspire Biopharma Holdings , Inc .: Aspire Biopharma Files Provisional Patent Application for Industry - First Sublingual Powder Formulation of Clopidogrel to Address Gastric Bleeding Risks",
  "description": "20260127T201500Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2026-01/67536217-aspire-biopharma-holdings-inc-aspire-biopharma-files-provisional-patent-application-for-industry-first-sublingual-powder-formulation-of-clopidogrel-200.htm",
  "published_at": "20260127T201500Z",
  "fetched_at": "2026-01-28T00:24:25.269376+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2026-01/67536217-aspire-biopharma-holdings-inc-aspire-biopharma-files-provisional-patent-application-for-industry-first-sublingual-powder-formulation-of-clopidogrel-200.htm",
    "url_mobile": "",
    "title": "Aspire Biopharma Holdings , Inc .: Aspire Biopharma Files Provisional Patent Application for Industry - First Sublingual Powder Formulation of Clopidogrel to Address Gastric Bleeding Risks",
    "seendate": "20260127T201500Z",
    "socialimage": "https://www.finanznachrichten.de/chart-aspire-biopharma-holdings-inc-aktie-intraklein-nasdaq.png",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}